Compare AbCellera Biologics Inc (ABCL) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Palo Alto Networks Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Palo Alto Networks Inc trades at $382.49 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 104.6× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | PANW | |
|---|---|---|
Market Cap | $2.99B | $312.80B |
Sector | Health | Technology |
52-Week High | $9.76 | $385.04 |
52-Week Low | $2.78 | $141.67 |
Enterprise Value | $2.58B | $311.76B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
